Since our founding in 2009, REGENXBIO has pioneered what’s possible in gene therapy. Today, we are advancing a pipeline of gene therapies designed to improve the lives of patients facing serious rare and retinal diseases and preparing to bring innovative new medicines to patients.
Our work is fueled by purpose and urgency because every day matters to patients and their families. At REGENXBIO, you’ll find meaningful opportunities to grow, collaborate, and contribute to the advancement of potentially transformative gene therapies. Together, our talented team is working to make a meaningful difference for patients and their families.
What we do matters. The opportunity
As VP, Global Rare Disease Franchise, you’ll lead the overall strategy and commercialization of REGENXBIO’s rare disease portfolio. With full accountability for business performance and P&L, you’ll lead the commercial strategy and launch of RGX-202 while shaping the growth and evolution of our rare disease franchise. Reporting to the Chief Commercial Officer, you'll lead the Rare Disease Franchise and Marketing organization, partnering cross-functionally to turn strategy into execution and deliver meaningful outcomes for patients, providers, and the company. As a member of the commercial leadership team, you’ll also help shape REGENXBIO’s global growth strategy and strengthen our leadership in rare disease.